Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

6 Reasons Advaxis May Be The Best Reward Vs. Risk In Healthcare
Seeking Alpha
Saturday, September 7, 2013 - 11:40am
tags:
Advaxis
Gilead Is A Gem Of A Biotech Stock Comment Now Follow Comments
Forbes
Saturday, September 7, 2013 - 11:39am
tags:
Gilead Sciences
Biotech Breakout Highlights Flawed ETF Thinking
Seeking Alpha
Saturday, September 7, 2013 - 11:38am
tags:
ETFs
Myriad rolls out next-gen Dx for 8 major cancers
Fierce Medical Devices
Friday, September 6, 2013 - 11:01am
tags:
cancer, cancer diagnostics, devices, Myriad Genetics
[video]Can This Troubled Pharma Giant Bounce Back?
Motley Fool
Friday, September 6, 2013 - 11:00am
tags:
Eli Lilly, patent cliff
KKR favoured in $1.5 bln Panasonic healthcare talks -sources
Reuters
Friday, September 6, 2013 - 10:49am
tags:
KKR, M&A, devices, Panasonic
'Doctor-2' in Elan, Wyeth insider trading case said to be well connected Alzheimer's doc
Fierce Pharma
Friday, September 6, 2013 - 10:44am
tags:
Elan, insider trading, Wyeth, physicians, Alzheimer's disease
Provectus Pharmaceuticals: Small Cap, Huge Upside
Seeking Alpha
Friday, September 6, 2013 - 10:42am
tags:
Provectus
Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble
Seeking Alpha
Friday, September 6, 2013 - 10:31am
tags:
Teva, Rexahn, RX-3117
Updated Vascepa Data And Why I Would Buy Into Amarin's Current Momentum
Seeking Alpha
Friday, September 6, 2013 - 10:29am
tags:
Vascepa, Amarin
Mallinckrodt's extended-release pain drug meets main goal of study
Reuters
Friday, September 6, 2013 - 10:25am
tags:
Mallinckrodt, MNK-795
Glaxo-Theravance Lung Drug Shows Strong Efficacy, FDA Say
Bloomberg
Friday, September 6, 2013 - 10:16am
tags:
GSK, Theravance, COPD, Anoro Ellipta
Merck poised for expansion of Zostavax shingles vax as demand grows
Fierce Pharma
Friday, September 6, 2013 - 9:17am
tags:
Zostavax, vaccines, shingles, Merck
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Friday, September 6, 2013 - 9:12am
tags:
Incyte, JAK inhibitors, Jakafi, myelofibrosis
Biogen may be capturing 50% of new MS patients, says Cowen
Yahoo/Fly on the Wall
Friday, September 6, 2013 - 8:58am
tags:
MS, Biogen Idec, multiple sclerosis, Tecfidera
Endo Health says FDA agreed to review its application for the testosterone injection Aveed
Yahoo/AP
Friday, September 6, 2013 - 8:57am
tags:
FDA, Endo Health Solutions, testosterone, Aveed
Novartis announces global licensing, research collaboration with Regenerex
Yahoo/Fly on the Wall
Friday, September 6, 2013 - 8:21am
tags:
Novartis, Regeneron, R&D, liscensing
Pfizer Looks Good Despite Disappointing Eliquis Sales
Seeking Alpha
Friday, September 6, 2013 - 8:20am
tags:
Pfizer, Merck, Bristol-Myers Squibb, Eliquis, DVT, bloodthinners
4 Healthcare Stock Stories Making Sector Headlines Thursday
Wall St. Cheat Sheet
Thursday, September 5, 2013 - 6:54pm
tags:
Celgene, MM-003, AlaicBronchial Thermoplasty, Boston Scientific, Aveed, Endo Health Solutions, Neuralstem
Theravance says lung disease drug TD-4208 succeeded in a midstage clinical trial
Yahoo/AP
Thursday, September 5, 2013 - 6:51pm
tags:
Theravance, TD-4208, COPD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.